查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088981

胰島素輸注裝置市場：按給藥方式、胰島素類型、分銷管道、最終用戶、應用和年齡層分類－2026-2032年全球市場預測

Insulin Delivery Devices Market by Delivery Method, Insulin Type, Distribution Channel, End User, Application, Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胰島素輸送設備市場規模將成長至 586.3 億美元，複合年成長率為 8.15%。

主要市場統計數據
基準年 2025 338.6億美元
預計年份：2026年 364.5億美元
預測年份 2032 586.3億美元
複合年成長率 (%) 8.15%

隨著糖尿病盛行率的上升以及醫療模式日益複雜、網路化和以患者為中心的趨勢，胰島素輸注設備的市場正在不斷擴大。世界衛生組織的報告顯示，到2022年，全球將有超過8.3億人患有糖尿病；國際糖尿病聯盟（IDF）估計，2021年全球20至79歲的成年人中，糖尿病患者人數為5.37億。這表明，胰島素筆、胰島素幫浦、貼片幫浦、智慧胰島素帽、輸注裝置和自動胰島素輸注系統等產品將持續受到市場需求的限制。

這一成長是由持續血糖監測、遠端醫療和基於價值的糖尿病管理模式的普及所推動的。對於製造商、保險公司和醫療保健提供者而言，他們的工作重點正從單純地部署醫療設備轉向可衡量的結果，例如延長血糖值維持在目標範圍內的時間、減少低血糖發作、提高遵守用藥、更安全地調整胰島素劑量以及降低長期併發症的風險。

胰島素給藥領域的變革性變化

連網胰島素筆、無導管胰島素幫浦、可互通的胰島素幫浦與患者血糖監測（CGM）系統以及自動胰島素輸注演算法正在重塑競爭格局。美國和歐洲的法規結構日益支持可互通的糖尿病相關技術，使患者和臨床醫生能夠組合使用相容的組件，同時促進硬體、軟體和資訊服務領域的創新。

人工智慧（AI）的累積影響

人工智慧 (AI) 對胰島素輸注設備，整體是根據血糖值趨勢調整基礎胰島素劑量的自動胰島素輸注系統，正產生累積的影響。當人工智慧分析與持續血糖監測 (CGM)、胰島素輸注史、飲食、活動水平和臨床背景相結合時，可以支援模式識別、劑量確定、預測警報和個人化指導。

主要區域洞察：亞太地區、北美地區、歐洲、拉丁美洲、中東和非洲

北美仍然是先進胰島素輸注設備的主要地區，這得益於其較高的糖尿病診斷率、完善的保險報銷管道、持續血糖監測儀（CGM）的廣泛應用以及獲得FDA批准的可互操作糖尿病技術。歐洲受益於結構化的醫療保健體系、健全的臨床指南以及聯網胰島素筆和胰島素幫浦使用率的提高，但由於各國醫療技術評估和保險公司政策的差異，保險報銷情況因國家而異。

主要區域集團概況：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協地區，由於都市區醫療基礎設施的完善、藥房可及性的提高以及行動優先的病人參與的普及，胰島素筆和聯網糖尿病管理工具的潛在市場正在擴大，但價格仍然是一個關鍵挑戰。在海灣合作理事會（GCC）國家，一些海灣國家的糖尿病盛行率位居世界前列，對糖尿病預防、專科診所和數位醫療的投入正在推動對高階胰島素幫浦、連網胰島素筆和遠端監測設備的需求。

主要胰島素給藥市場的關鍵國別洞察

美國在自動胰島素輸注技術創新、與持續血糖監測（CGM）的整合以及公共醫療保險報銷方面處於主導地位。同時，加拿大透過省級醫療保險覆蓋和專科醫生主導的醫療服務，正穩步推進相關技術的普及。在墨西哥和巴西，私人保險、公共糖尿病計畫以及內分泌科診療服務的進步，為耐用型胰島素筆和專用胰島素幫浦的引入創造了重要機會。

為行業領導者提供的實用建議

產業領導者應優先考慮可互通的設備生態系統、真實世界數據和經濟實惠的策略。成功的產品系列必須整合可靠的胰島素筆、胰島素幫浦、貼片幫浦、耗材、軟體和病患支援服務，同時在提高用藥依從性、延長血糖達標時間、減少低血糖發生率和改善生活品質方面展現出可衡量的進步。

調查方法

本執行摘要採用系統性的二手研究途徑編寫，依據公共衛生資料、監管資訊、臨床證據、報銷趨勢和公開的行業資訊。主要參考文獻包括世界衛生組織 (WHO)、國際糖尿病聯盟 (IDF)、美國疾病管制與預防中心 (CDC)、美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA)、各國衛生機構、同行評審的糖尿病技術文獻、臨床指南和最新的公共政策資訊。

結論

胰島素輸注設備市場正朝著更互聯、自動化和循證的方向發展。糖尿病盛行率的上升、持續血糖監測（CGM）的廣泛應用以及臨床上對更安全胰島素管理日益成長的需求，都推動了對胰島素筆、智慧胰島素筆、胰島素幫浦、貼片幫浦、輸注裝置和自動化胰島素輸注系統的需求成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 胰島素輸注裝置市場：以輸注方式分類

  • 胰島素筆
  • 胰島素幫浦
  • 胰島素注射器
  • 噴射注射器

第8章：胰島素輸注裝置市場：依胰島素類型分類

  • 中間類型
  • 長效型
  • 預混合料型
  • 快速起效

第9章：胰島素輸注裝置市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章：胰島素輸注設備市場：依最終用戶分類

  • 門診部
  • 診所
  • 居家照護環境
  • 醫院

第11章 胰島素輸注裝置市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第12章 胰島素輸注裝置市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第13章 胰島素輸注裝置市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 胰島素輸注裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 胰島素輸注裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • B. Braun SE
  • Biocon
  • Debiotech SA
  • Eli Lilly and Company
  • Embecta Corp.
  • Gerresheimer AG
  • ICU Medical, Inc.
  • Insulet Corporation
  • Jiangsu Delfu medical device Co.,Ltd
  • Johnson & Johnson Services, Inc.
  • MannKind Corporation
  • Medtronic PLC
  • Nipro Corporation
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Roche Diabetes Care, Inc.
  • Sanofi SA
  • Sequel Med Tech, LLC
  • SOOIL Developments Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Wockhardt Limited
  • Ypsomed AG
Product Code: MRR-ED54C46E8A4A

The Insulin Delivery Devices Market is projected to grow by USD 58.63 billion at a CAGR of 8.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 33.86 billion
Estimated Year [2026] USD 36.45 billion
Forecast Year [2032] USD 58.63 billion
CAGR (%) 8.15%

The insulin delivery devices market is expanding as diabetes prevalence rises and care models move toward more precise, connected, and patient-centered treatment. WHO reports that more than 830 million people were living with diabetes in 2022, while the International Diabetes Federation estimates 537 million adults aged 20-79 had diabetes in 2021, underscoring sustained demand for insulin pens, insulin pumps, patch pumps, smart caps, infusion sets, and automated insulin delivery systems.

Growth is supported by broader use of continuous glucose monitoring, telehealth, and value-based diabetes management. For manufacturers, payers, and providers, the priority is shifting from device adoption alone to measurable outcomes, including better time-in-range, fewer hypoglycemic events, improved adherence, safer insulin titration, and lower long-term complication risk.

Transformative Shifts in the Insulin Delivery Landscape

The competitive landscape is being reshaped by connected insulin pens, tubeless pumps, interoperable pump-CGM ecosystems, and automated insulin delivery algorithms. Regulatory pathways in the United States and Europe increasingly support interoperable diabetes technologies, enabling patients and clinicians to combine compatible components while encouraging innovation across hardware, software, and data services.

At the same time, affordability, training, reimbursement, cybersecurity, usability, and supply-chain resilience remain decisive market factors. Companies that simplify onboarding, reduce device burden, document clinical value, and support remote care are better positioned as diabetes care moves from episodic clinic visits to continuous digital management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across insulin delivery devices, especially in automated insulin delivery systems that adjust basal insulin based on glucose trends. AI-enabled analytics can support pattern recognition, dose decision support, predictive alerts, and personalized coaching when integrated with CGM, insulin dosing history, meals, activity, and clinical context.

The opportunity is significant, but adoption depends on clinical validation, transparent performance, privacy protection, and safe human oversight. Industry leaders must treat AI as a regulated clinical capability rather than a marketing feature, with evidence generation focused on time-in-range, hypoglycemia reduction, usability, equity, alarm burden, and real-world adherence.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains a leading region for advanced insulin delivery devices, supported by high diabetes diagnosis rates, established reimbursement channels, broad CGM adoption, and FDA-cleared interoperable diabetes technologies. Europe benefits from structured health systems, strong clinical guidelines, and growing use of connected pens and pumps, although reimbursement varies by country under national health technology assessment and payer policies.

Asia-Pacific shows the strongest structural opportunity due to large diabetes populations in China, India, Japan, South Korea, and Australia, combined with expanding specialty care, digital health access, and rising awareness of insulin intensification. Latin America is advancing through private-sector adoption and public diabetes programs, with Brazil and Mexico anchoring regional demand. The Middle East faces a high diabetes burden and rising investment in premium care, specialist clinics, and digital health infrastructure. Africa remains underpenetrated, with access, affordability, insulin availability, cold-chain reliability, and clinician training shaping near-term demand.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, expanding urban healthcare infrastructure, pharmacy access, and mobile-first patient engagement are improving the addressable base for insulin pens and connected diabetes tools, although affordability remains critical. GCC countries are investing in diabetes prevention, specialty clinics, and digital health because diabetes prevalence is among the world's highest in several Gulf states, supporting demand for premium pumps, connected pens, and remote monitoring.

The European Union is shaped by medical device regulation, health technology assessment, data protection requirements, and country-level reimbursement, favoring clinically proven systems with documented patient benefit. BRICS markets combine large patient pools with uneven access, creating demand for scalable, durable, and cost-effective insulin delivery devices. G7 countries lead in premium pump, CGM, connected pen, and AI-enabled adoption due to mature reimbursement and specialist infrastructure, while NATO members overlap substantially with regulated markets where cybersecurity, supply continuity, and device data resilience are strategic priorities.

Key Country Insights Across Major Insulin Delivery Markets

The United States leads in automated insulin delivery innovation, CGM integration, and commercial reimbursement, while Canada shows steady uptake through provincial coverage and specialist-led care. Mexico and Brazil present large opportunities for durable insulin pens and selective pump adoption as private coverage, public diabetes initiatives, and access to endocrinology services evolve.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from strong diabetes care pathways, national clinical guidance, and established reimbursement mechanisms, while Russia faces access, procurement, and regional care variability. China and India represent the largest scale opportunities due to population size, rising diabetes incidence, and expanding hospital and digital health networks. Japan, Australia, and South Korea support high-quality adoption through advanced clinical infrastructure, reimbursement mechanisms, strong patient education, and consumer readiness for connected health technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable device ecosystems, real-world evidence, and affordability strategies. Winning portfolios will combine reliable insulin pens, pumps, patch pumps, consumables, software, and patient support services while proving measurable improvements in adherence, time-in-range, hypoglycemia reduction, and quality of life.

Companies should also strengthen cybersecurity, AI governance, clinician education, human factors design, and payer engagement. Partnerships with CGM developers, telehealth providers, pharmacies, and health systems can accelerate adoption, while localized pricing, training, and service models are essential for emerging markets where access barriers remain high.

Research Methodology

This executive summary is developed using a structured secondary research approach grounded in public health data, regulatory information, clinical evidence, reimbursement trends, and publicly available industry disclosures. Core reference points include WHO, the International Diabetes Federation, CDC, FDA, EMA, national health agencies, peer-reviewed diabetes technology literature, clinical guidelines, and publicly available policy updates.

The analysis triangulates epidemiology, technology adoption, regulatory direction, care delivery trends, reimbursement signals, and regional access factors. Insights are written to support strategic decision-making for insulin delivery device manufacturers, investors, healthcare providers, and digital health partners without relying on unverified claims, unsupported estimates, market sizing, market share, or forecasting.

Conclusion

The insulin delivery devices market is entering a more connected, automated, and evidence-driven phase. Rising diabetes prevalence, broader CGM adoption, and the clinical need for safer insulin management are increasing demand for insulin pens, smart pens, pumps, patch pumps, infusion sets, and automated insulin delivery systems.

Future leadership will depend on balancing innovation with access. Companies that deliver clinically validated, interoperable, secure, user-friendly, and affordable solutions will be best positioned to improve diabetes outcomes across mature and emerging markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Insulin Delivery Devices Market, by Delivery Method

  • 7.1. Insulin Pens
  • 7.2. Insulin Pumps
  • 7.3. Insulin Syringes
  • 7.4. Jet Injectors

8. Insulin Delivery Devices Market, by Insulin Type

  • 8.1. Intermediate-Acting
  • 8.2. Long-Acting
  • 8.3. Pre-Mixed
  • 8.4. Rapid-Acting

9. Insulin Delivery Devices Market, by Distribution Channel

  • 9.1. Hospital Pharmacies
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies

10. Insulin Delivery Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Clinics
  • 10.3. Homecare Settings
  • 10.4. Hospitals

11. Insulin Delivery Devices Market, by Application

  • 11.1. Gestational Diabetes
  • 11.2. Type 1 Diabetes
  • 11.3. Type 2 Diabetes

12. Insulin Delivery Devices Market, by Age Group

  • 12.1. Adult
  • 12.2. Geriatric
  • 12.3. Pediatric

13. Insulin Delivery Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Insulin Delivery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Insulin Delivery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Ascensia Diabetes Care Holdings AG
  • 17.3. B. Braun SE
  • 17.4. Biocon
  • 17.5. Debiotech SA
  • 17.6. Eli Lilly and Company
  • 17.7. Embecta Corp.
  • 17.8. Gerresheimer AG
  • 17.9. ICU Medical, Inc.
  • 17.10. Insulet Corporation
  • 17.11. Jiangsu Delfu medical device Co.,Ltd
  • 17.12. Johnson & Johnson Services, Inc.
  • 17.13. MannKind Corporation
  • 17.14. Medtronic PLC
  • 17.15. Nipro Corporation
  • 17.16. Novo Nordisk A/S
  • 17.17. Owen Mumford Ltd.
  • 17.18. Roche Diabetes Care, Inc.
  • 17.19. Sanofi S.A.
  • 17.20. Sequel Med Tech, LLC
  • 17.21. SOOIL Developments Co., Ltd
  • 17.22. Tandem Diabetes Care, Inc.
  • 17.23. Terumo Corporation
  • 17.24. Wockhardt Limited
  • 17.25. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSULIN PENS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSULIN PENS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSULIN PENS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INSULIN SYRINGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INSULIN SYRINGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INSULIN SYRINGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JET INJECTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JET INJECTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JET INJECTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTERMEDIATE-ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG-ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LONG-ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG-ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PRE-MIXED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PRE-MIXED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PRE-MIXED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RAPID-ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RAPID-ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAPID-ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOMECARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GCC INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GCC INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. G7 INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 145. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. G7 INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. NATO INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 152. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. NATO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 167. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 174. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 195. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 209. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 216. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 223. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 237. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 244. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 251. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
  • TABLE 258. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)